Life Sciences
Helping clients outperform and innovate across the life sciences industries
How we help clients
Our people
Reinout Goedvolk
Senior Partner, and Global Coleader, Life SciencesAmsterdam
Co-leads our global Life Sciences Practice, advises life sciences companies, including biopharma, medtech, and private equity...
Robert Linden
Senior PartnerSan Francisco
Co-leads our global Life Sciences Practice, advising a broad range of healthcare clients—from early-stage innovators to...
Featured capabilities
POBOS
POBOS provides information on cost, productivity and quality, supply chain performance, and quality performance across more than 35 pharmaceutical and biotech companies. Companies can use the information to understand productivity drivers and their impact and quickly focus efforts on the highest value areas.
Scientific AI
We develop and deploy Artificial Intelligence methods to accelerate innovation and unlock value in Research and Development across industries. Our sophisticated Artificial Intelligence and Machine Learning capabilities have been developed to help across the entire R&D process.
Featured insights
Article
How medtech companies can create value via inventory optimization
-
With more efficient inventory management, medtechs can reduce inventory by up to 30 percent—freeing up cash and reducing write-offs.
Article
Closing the women’s health gap: Biopharma’s untapped opportunity
-
Most top pharma companies derive more than 60 percent of their revenue from therapies for diseases that affect women uniquely, differently, or disproportionately, putting them in a prime position to close the sex- and gender-based health gap.
Article
Putting people at the center of the R&D talent model in life sciences
-
Rapid advancements in science and technology are challenging pharma and biotech companies’ approaches to talent. What R&D skills do they need today, and how can they sustain this workforce?
Rapport
Medtech Pulse: Thriving in the next decade
-
Medtech leaders are devising strategies to catch the next wave of value creation amid uncertain macroeconomics and evolving industry trends.